Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial
Ramakrishnan S., Russell REK., Mahmood HR., Krassowska K., Melhorn J., Mwasuku C., Pavord ID., Bermejo-Sanchez L., Howell I., Mahdi M., Peterson S., Bengtsson T., Bafadhel M.